US Drug Recall Register

Is Clopidogrel recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Clopidogrel (7 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Clopidogrel. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Ongoing

Clopidogrel Tablets USP

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-8190-9 D-0513-2023
Class II · Moderate risk Terminated

Clopidogrel Tablets USP

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-218-10 D-0380-2023
Class II · Moderate risk Terminated

Clopidogrel Tablets

Reason Presence of foreign matter

Macleods Pharma Usa Inc NDC 33342-060-15 D-0787-2021
Class II · Moderate risk Terminated

Clopidogrel Tablets

Reason Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.

Dr. Reddy's Laboratories, Inc. NDC 55111-671-31 D-0294-2019
Class II · Moderate risk Terminated

Clopidogrel Tablets

Reason Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.

Dr. Reddy's Laboratories, Inc. NDC 55111-671-31 D-0283-2019
Class I · High risk Terminated

Clopidogrel Tablets

Reason LABELING: LABEL MIX-UP. Simvastatin tablets, USP 10 mg were found in bottles labeled as Clopidogrel tablets, USP 75 mg.

International Laboratories, LLC NDC 54458-888-16 D-0472-2018
Class II · Moderate risk Terminated

Clopidogrel Bisulfate active pharmaceutical ingredient packaged…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-597-2015